In the HDM mouse model of asthma, SM17 reduced lung pathology score, eosinophil infiltration, and inflammatory cytokine (IL-4, IL-5, IL-13) secretion to levels comparable to dexamethasone-treated mice (79). Here, IL13 is linked to asthma.